Insider buying last 90 days
No open-market insider purchases were filed for AMN in the last 90 days.
From Form 4 filings, dated to when each was filed.
Oct 12 close
This week brings a string of analyst actions alongside continued commentary on AMN Healthcare's staffing demand trends. Argus raised its target price to $39.00, while BMO Capital reiterated a Buy rating and raised its target to $43.00, upgrading the stock to "Outperform." Coverage also points to strength in technology-enabled solutions and higher-margin technology and language services as drivers behind the positive sentiment. A scheduled announcement confirms that third-quarter 2026 results and fourth-quarter guidance will be released on 5 November.
AMN closes at $36.28, down 0.7%, with the close sitting above both the 50-day average of $34.51 and the 200-day average of $26.52. The one-month return stands at 8.8% and the six-month return at 95.3%. The GekkoIndex reads 53, placing the stock in the Neutral zone. Gekko Fair Value is set at $54.57, leaving price 33.5% below that level.
Earnings are due on 5 November, 24 days away, falling inside a typical 20-trading-day holding window, with the last reaction move registering 38.1% and an average absolute reaction of 15.7% across prior quarters. Seasonality over the next 20 trading days has averaged -5.2% across 5 years, rising in 2 of those years. No insider, Congress, or unusual options activity appears in the current window. Analyst consensus across 7 firms shows 2 buy, 4 hold, and 1 sell ratings, with a consensus target of $36.14.
Written by AI from the Oct 12, 2026 close and checked automatically against the figures on this page.
AMN Healthcare Services scores 2 supportive, 1 mixed and 2 headwinds across the 5 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
2 supportive1 mixed2 headwinds
Above 50 and 200-day
Close $36.28 is above the 50-day ($34.51) and 200-day ($26.52) averages, and the 50-day is above the 200-day.
See the chart53, Neutral
Reading 53 is in the Neutral zone.
See the GekkoIndex33.5% below
Price is 33.5% below Gekko Fair Value (more than 5% below).
See fair valueNo data
No insider, Congress or unusual options activity in the window.
See smart moneyReports in 24 days
Reports on Nov 5, 2026, 24 days away — inside a typical 20-trading-day hold.
See earnings−5.2% on average
From this point in the calendar, the next 20 trading days averaged −5.2% over 5 years, rising in 2 of them.
See seasonalityA description of current data, not a recommendation. How this page works
AMN Healthcare Services closed at $36.28 on Oct 12, 2026, +91.8% over the past year, inside a 52-week range of $14.97 to $38.44.
Use the left and right arrow keys to read daily values.
Put AMN on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
AMN Healthcare Services provides staffing and workforce services to hospitals and other healthcare facilities across the United States. It is widely associated with placing registered nurses in travel, rapid-response, and local assignments, alongside a broader pool of allied health workers such as therapists, technologists, lab staff, and pharmacists.
The company organizes its work into three areas. One places nurses and allied health professionals and offers revenue cycle management support. Another arranges locum tenens physicians, interim healthcare leadership, executive searches, and permanent physician placement. A third covers technology-driven services, including language interpretation, vendor management systems, workforce optimization, telehealth, and credentialing support. These services reach healthcare organizations through a collection of operating brands AMN has built or acquired over time, each tied to a particular staffing niche.
AMN Healthcare was founded in 1985 and is headquartered in Dallas, Texas. Its shares trade on the NYSE under the ticker AMN.
AMN Healthcare Services’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 53, in the Neutral zone, up 5.7 points over five sessions.
Up 5.7 points over five sessions.
Reading for Oct 12, 2026
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 68 | +2.8% | +6.0% | ||
| Accumulation | 271 | 0.0% | −0.4% | ||
| Neutral (current zone) | 326 | −0.7% | −2.6% | ||
| Distribution | 12 | −2.3% | −13.7% | ||
| Selling | 5 | Too few readings yet | |||
Average AMN share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Neutral readings averaged +1.1% over 20 days. Past behaviour doesn’t guarantee future results.
Neutral zone: No clear directional signal. About the five zones →
AMN Healthcare Services trades 33.5% below Gekko Fair Value of $54.57, so the shares are undervalued on Gekko’s estimate.
Gekko’s own estimate of what AMN Healthcare Services shares are worth, recalculated every trading day.
$54.57
Gekko Fair Value, Oct 10, 2026
33.5% Undervalued
At the end of Aug 2026 the price was 1.7% below the estimate.
No open-market insider purchases were filed for AMN Healthcare Services, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
No open-market insider purchases were filed for AMN in the last 90 days.
From Form 4 filings, dated to when each was filed.
No trades in AMN were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
AMN Healthcare Services has been buying back its own shares.
From company filings.
AMN Healthcare Services reports on Nov 5, 2026, after the close (24 days away), and beat the EPS estimate in 7 of its last 8 reports.
Nov 5, 2026
Expected after the close, 24 days away
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| May 7, 2026 | $2.10 est $0.08 | $1.38B est $1.23B | +38.1% |
| Feb 19, 2026 | $0.22 est $0.22 | $748.2M est $723.7M | +13.1% |
| Nov 6, 2025 | $0.39 est $0.19 | $634.5M est $723.1M | −13.4% |
| Aug 7, 2025 | $0.30 est $0.17 | $658.2M est $639.6M | +0.1% |
| May 8, 2025 | $0.45 est $0.19 | $689.5M est $670.1M | +12.2% |
| Feb 20, 2025 | $0.75 est $0.49 | $734.7M est $694.4M | +15.7% |
| Nov 7, 2024 | $0.61 est $0.57 | $687.5M est $668.0M | −29.5% |
| Aug 8, 2024 | $0.98 est $0.76 | $740.7M est $740.4M | −3.1% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Analysts’ average 12-month price target for AMN Healthcare Services is $36.14, −0.4% from the last close, from 7 firms rating the stock in the last 90 days.
Each firm’s latest rating in the last 90 days: 7 firms.
| Date | Firm | Target | vs price |
|---|---|---|---|
| Oct 9 | BMO Capital | $43 | +18.5% |
| Sep 25 | Truist Financial | — | — |
| Sep 21 | Truist Financial | — | — |
| Sep 11 | BMO Capital | $40 | +10.3% |
| Aug 10 | BMO Capital | $38 | +4.7% |
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Over the next 20 trading days from Oct 10, AMN Healthcare Services averaged −5.2% across the last 5 years, rising in 2 of them.
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | −3.2% | 2 of 5 |
| Next 10 trading days | −0.9% | 3 of 5 |
| Next 15 trading days | 0.0% | 3 of 5 |
| Next 20 trading days | −5.2% | 2 of 5 |
| Next 30 trading days | −11.0% | 2 of 5 |
For scale, AMN’s typical 20-trading-day move in either direction is about 8.2%.
AMN Healthcare Services’s market cap is $1.41B, with a P/E ratio of 13.2 and revenue of $3.43B over the last twelve months.
Coverage of AMN Healthcare Services this week reads positive: 6 positive, 4 neutral and 0 negative headlines.
AMN Healthcare Services’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| KFYKorn Ferry | Accumulation | 21.2% below |
| RHIRobert Half | Accumulation | 10.6% below |
| MANManpowerGroup | Accumulation | 35.8% below |
| UPWKUpwork | Neutral | 43.3% below |
| KFRCKforce | Accumulation | 4.5% above |
| BBSIBarrett Business Services | Accumulation | 3.7% below |
A peer links to its own page where one exists.
AMN Healthcare Services’s market cap is $1.41B at the Oct 12, 2026 close of $36.28, with 38.73M shares outstanding. The shares trade on a P/E ratio of 13.2.
The consensus analyst 12-month price target for AMN Healthcare Services is $36.14, −0.4% from the last close. Of the 7 firms that rated the stock in the last 90 days, 2 rate it a buy, 4 a hold and 1 a sell. Gekko doesn’t publish price predictions of its own.
On Gekko’s estimate AMN Healthcare Services is undervalued: the Oct 12, 2026 close of $36.28 is 33.5% below Gekko Fair Value of $54.57. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
AMN Healthcare Services is expected to report on Nov 5, 2026, after the market closes (24 days away). Analysts expect earnings of $0.23 per share on revenue of $649.5M. AMN Healthcare Services beat the earnings estimate in 7 of its last 8 reports, moving 15.7% on average across the report.
AMN Healthcare Services’s 52-week high is $38.44 and its 52-week low is $14.97; it closed at $36.28 on Oct 12, 2026, +91.8% over the past year. Over the last five years the shares peaked at $129.12 on Dec 27, 2021.
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 2 of the 5 items with data read as supportive (trend and fair value), 1 as mixed (gekkoindex) and 2 as headwinds (earnings risk and seasonality). The checklist is a description of current data, not a recommendation.
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,408 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.Type a ticker or company name. Press Esc to close.